Newbridge Financial Services Group, Inc. Greenwich Life Sciences, Inc. Transaction History

Newbridge Financial Services Group, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Sep 11, 2024	BUY	$12.07 - $19.04 $4,828 - $7,616	400 Added 26.67%	1,900 $32,000
Q2 2023 Jul 21, 2023	BUY	$9.58 - $13.2 $5,748 - $7,920	600 Added 66.67%	1,500 $14,000
Q1 2023 Apr 18, 2023	BUY	$12.12 - $20.8 $4,848 - $8,320	400 Added 80.0%	900 $12,000
Q3 2021 Oct 27, 2021	BUY	$38.65 - $46.11 $19,325 - $23,055	500 New	500 $20,000

1.1M

Ticker GLSI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,848,200
Market Cap $158M
Description
Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which has completed Phase IIb clinical trial to prevent breast cancer recurrences in patients who ha...

Get notified when there are updates to the investment portfolio of Newbridge Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Newbridge Financial Services Group, Inc. with notifications on news.